» Authors » T R Vazquez-Rodriguez

T R Vazquez-Rodriguez

Explore the profile of T R Vazquez-Rodriguez including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 261
Followers 0
Related Specialty
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Baerlecken N, Linnemann A, Gross W, Moosig F, Vazquez-Rodriguez T, Gonzalez-Gay M, et al.
Ann Rheum Dis . 2012 Jan; 71(6):943-7. PMID: 22228484
Objectives: Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are relatively common inflammatory disorders. Establishing the diagnosis however may be difficult, since so far no specific biomarkers of the disorders...
2.
Garcia-Bermudez M, Gonzalez-Juanatey C, Rodriguez-Rodriguez L, Miranda-Filloy J, Perez-Esteban S, Vazquez-Rodriguez T, et al.
Clin Exp Rheumatol . 2011 Sep; 29(4):681-8. PMID: 21906432
Objectives: Visfatin is an adipokine encoded by the NAMPT (PBEF1) gene. In this study we assessed the potential association of two NAMPT gene polymorphisms with disease susceptibility and cardiovascular (CV)...
3.
Rodriguez-Rodriguez L, Garcia-Bermudez M, Gonzalez-Juanatey C, Vazquez-Rodriguez T, Miranda-Filloy J, Fernandez-Gutierrez B, et al.
Tissue Antigens . 2011 Mar; 77(4):291-7. PMID: 21388351
To determine the contribution of the vascular endothelial growth factor A (VEGFA) rs2010963 (-634 G>C) and rs1570360 (-1154 G>A) polymorphisms to the risk of cardiovascular (CV) disease in a series...
4.
Garcia-Bermudez M, Gonzalez-Juanatey C, Rodriguez-Rodriguez L, Vazquez-Rodriguez T, Miranda-Filloy J, Fernandez-Gutierrez B, et al.
Clin Exp Rheumatol . 2011 Mar; 29(2):293-8. PMID: 21385539
Objectives: To assess the potential association between LEP rs2167270 (19 G>A) gene polymorphism and disease susceptibility and cardiovascular disease (CV) in patients with rheumatoid arthritis (RA). Methods: 773 patients fulfilling...
5.
Rodriguez-Rodriguez L, Garcia-Bermudez M, Gonzalez-Juanatey C, Vazquez-Rodriguez T, Miranda-Filloy J, Fernandez-Gutierrez B, et al.
Tissue Antigens . 2010 Nov; 77(1):74-8. PMID: 21073447
To assess the potential association between ADIPOQ rs266729 and rs1501299 gene polymorphisms, either isolated or in combination, and cardiovascular disease in patients with rheumatoid arthritis (RA), 674 patients seen at...
6.
Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez T, Rodriguez L, Miranda-Filloy J, Pascual-Salcedo D, et al.
Clin Exp Rheumatol . 2010 Sep; 28(5):695-701. PMID: 20822712
Objectives: To determine whether the PTPN22, STAT4 and TRAF1/C5 gene polymorphisms may be implicated in the development of cardiovascular (CV) events and subclinical atherosclerosis manifested by the presence of endothelial...
7.
Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez T, Torres O, Miranda-Filloy J, Llorca J, et al.
Clin Exp Rheumatol . 2010 Mar; 28(1):68-72. PMID: 20346241
Objectives: To assess whether the polymorphism of the macrophage migration inhibitory factor (MIF) gene at the position -173 is implicated in the disease susceptibility, risk of cardiovascular (CV) events and...
8.
Gonzalez-Gay M, Vazquez-Rodriguez T, Garcia-Unzueta M, Berja A, Miranda-Filloy J, de Matias J, et al.
Clin Exp Rheumatol . 2010 Mar; 28(1):56-62. PMID: 20346239
Background And Objective: Visfatin is an insulin-mimetic adipokine. In non-rheumatoid arthritis (RA) patients circulating levels of visfatin are correlated with the amount of visceral fat. Recent studies have disclosed an...
9.
Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez T, Miranda-Filloy J, Llorca J, Martin J, et al.
Clin Exp Rheumatol . 2010 Feb; 27(6):964-70. PMID: 20149313
Objective: To determine whether the interleukin (IL)6 -174 gene polymorphism may influence the development of subclinical atherosclerosis manifested by the presence of endothelial dysfunction in RA patients. Patients And Methods:...
10.
Amoli M, Miranda-Filloy J, Vazquez-Rodriguez T, Ollier W, Gonzalez-Gay M
Clin Exp Rheumatol . 2009 Aug; 27(1 Suppl 52):S142-3. PMID: 19646363
No abstract available.